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Abstract 
 
Increasing emphasis on interprofessionalism and teamwork in healthcare renders 
psychologists’ collaborations critical and invites reexamination of psychologists’ 
roles related to medications.  The Collaboration Level outlined by the APA’s Ad 
Hoc Task Force is more achievable and in synch with health reform than 
prescription privileges (RxP).  RxP remains controversial due to training and 
safety concerns, lacking support from health professionals, psychologists, and 
consumers.  Differences in educational preparation of psychologists relative to 
prescribing professionals are discussed.  Enactment of only three of 170 RxP 
initiatives reveals RxP to be a costly, ineffectual agenda.  Alternatives (e.g., 
integrated care, collaboration, telehealth) increase access without risks 
associated with lesser medical knowledge.  Concerns about RxP and the 
movement toward team-based care warrant reconsideration of the profession’s 
objectives regarding psychopharmacology. 
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Psychologists and Medications in the Era of Interprofessional Care:  
Collaboration is Less Problematic and Costly Than Prescribing 
 
The premise that doctoral-level psychologists should prescribe psychoactive 
medications to meet mental health needs that are unmet by current prescribers, 
while theoretically helpful if done well, warrants reassessment as we enter an era 
emphasizing team-based healthcare.  Concerns about the background, breadth 
and comprehensiveness of training for prescribing that the American 
Psychological Association (APA) currently advocates to complement 
psychologists’ doctoral training (i.e., most of which is not oriented toward 
preparing to prescribe) have been raised; many psychologists believing that if 
psychologists are to prescribe their knowledge and training should be equivalent 
with that of other prescribers (Baird, 2007).  Compromised training for prescribing 
raises questions about quality and safety that pose both regulatory and public 
health concerns, and uneasiness for numerous stakeholders. Consideration of 
whether or not organized psychology should pursue prescriptive authority also 
should be assessed within the context of existing alternatives—e.g., 
interdisciplinary care, in which psychologists collaborate with other professionals 
whose medical training allows more comprehensive management of medications 
(Butler et al., 2008; Institute of Medicine, Committee on Crossing the Quality 
Chasm: Adaptation to Mental Health and Addictive Disorder, 2006).  
This article begins with a brief review of medications, then explores the roles 
of collaboration and interprofessional care in the context of increasingly 
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compelling healthcare trends that provide psychologists opportunities to 
contribute substantively to patient care, but that lack the controversy of the 
agenda promoting prescription privileges for psychologists (RxP).  We also 
review some of the history and concerns about psychologist prescribing, the 
relative limitations of the APA training model, and the impact of the pursuit of 
prescription privileges on the field, including the limited success and substantial 
costs of its legislative record. 
Medication Trends 
Medications serve important roles in the arsenal of mental health treatments. 
According to the Substance Abuse and Mental Health Services Administration 
(SAMHSA; 2012), use of psychoactive medications increased by 96% from 127.2 
million prescription filled in 1998 to 248.8 million prescription filled in 2007 in the 
US.  In 1998, the market for adult psychoactive medication expenditures was an 
estimated $10 billion. A decade later, psychoactive medication costs were 
estimated around $25 billion (SAMHSA, 2012).  During this same period 
Americans receiving medication-only treatment for mental health problems 
increased by 13.5%.  By contrast, Americans getting combined psychotherapy 
and medication decreased from 40.0% to 32.1%, yielding a 13.3% decrease from 
55.9% to 42.6% in the percentage engaging in psychotherapy as part of their 
treatment. These trends exist in the context of emerging evidence of the relative 
benefits of combined treatments (e.g., Cuijpers, Dekker, Hoon, & Andersson, 
2009).  
Collaboration and Prescribing     5	   	  
The locus of care in which psychopharmacological approaches are used for 
treating mental health disorders is broad.  Up to two-thirds of individuals with 
mental health and/or substance use disorders are treated by physicians or other 
healthcare providers in the U.S. (Wang, Lane, Olfson, Pincus, Wells, & Kessler, 
2005) and internationally (Wang et al., 2007).  Many additional patients who are 
seen in primary care settings have sub-clinical mental health issues that may 
complicate diagnosis/treatment for physical health problems (Kessler et al., 
2005).  Despite the heterogeneous settings where patients obtain some type of 
care, nearly 70% of individuals with mental health conditions have been 
estimated to receive no treatment for their underlying mental health problems 
(Kessler et al., 2005).  Of the minority who do receive mental health treatment, 
few are treated with evidence-based approaches that have been shown to be 
effective (Wang et al., 2002; Wang et al., 2007).   
The number of prescriptions written by primary care physicians for 
psychotropic medications has increased dramatically since the mid 1990s 
(Lieberman, 2003).  Physicians, physician assistants and nurse practitioners, for 
example, wrote approximately 70% of all anxiolytic prescriptions, 68% of all 
antidepressant prescriptions, 57% of all prescriptions for stimulants, 43% of all 
anti-psychotics, and 28% of mood stabilizers between August, 2006 and July, 
2007 (DuBosar, 2009).  Recent data question the efficacy of the most prescribed 
psychotropic medication, antidepressants, in treating all but severe symptoms 
(Fournier et al., 2010).  There have been calls to re-think medications as a first 
line form of treatment (Carlat, 2010) and concerns about whether medications 
Collaboration and Prescribing     6	   	  
might be partially responsible for worsening mental health outcomes (Whitaker, 
2010) and for inducing various iatrogenic problems (e.g., (Gentile, 2011; Akiskal 
& Benazzi, 2006). 
 Psychologists harbor a range of views of medications and what roles 
psychologists might best play vis a vis medications (Hayes, Walser, & Bach, 
2002).  Whereas most recognize the benefits medications confer for at least 
some of their patients, many are concerned about potential problems that can be 
associated with medications, such as adverse effects, risks of abuse, and trends 
toward overprescribing. 
Although shortages of psychiatrists have long been recognized (Pardes & 
Pincus, 1983), as public acceptance of psychoactive medications has increased 
demand for psychopharmaceuticals, the limited access to psychiatrists has 
gained more attention.  Psychologists have been remarkably silent about 
advocating for increased funding for training psychiatrists, which arguably would 
be the most direct solution to that problem.  Instead, RxP proponents have 
identified access problems to psychiatrists as a main justification for RxP.  
Among psychologists, diverse views abound about how to ameliorate the 
problem of patients facing barriers to providers for psychoactive prescriptions.  
Advocates of RxP argue that securing prescription privileges provides 
psychologists direct roles, including the “power to not prescribe, or to help wean 
patients off medications” (Stambor, 2006, p. 30).  On the other hand, RxP 
opponents contend that collaboration and interprofessional practice are safer and 
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more effective approaches by which psychologists can work in conjunction with 
prescribers to effectively address patients’ health and mental health needs. 
Collaboration: A Compelling Alternative to RxP 
Whereas specialty mental health services are available from various mental 
health professionals (psychologists, marriage and family therapist, social workers, 
psychiatrists, etc.; Robiner, 2006), for individuals experiencing mental health 
problems general medical settings present critical points of care within the 
healthcare system.  Even patients who recognize their own mental health 
challenges may be reluctant to seek out specialty mental health care due to 
various concerns such as finances, insurance coverage, convenience, time, 
services location, referral inefficiencies, and stigma.  This latter concern seems 
particularly true for ethnic minorities (Snowden & Pingitore, 2002; Vega, Kolody, 
Aguilar-Gaxiola, & Catalano, 1999).  Providing mental health services in primary 
care settings facilitates patients’ acceptance of referrals for service, provides 
greater convenience of co-located services, builds on the already established 
trust with primary care providers, and increasingly takes advantage of the 
proximity of multiple types of providers working as a team (Frank, Bray, McDaniel, 
& Heldring, 2003).   
Primary care settings are important loci of mental health care delivery in that 
there are a far greater number of physicians and “mid-level providers” (i.e., nurse 
practitioners and physician assistants) than other mental health prescribers (i.e., 
psychiatrists, prescribing psychologists) who provide basic mental health 
services.  Nationally, there are an estimated 83,600 physician assistants (Bureau 
Collaboration and Prescribing     8	   	  
of Labor Statistics, 2010) and 105,700 nurse practitioners (Bureau of Labor 
Statistics, 2012), who by virtue of their sheer numbers are likely to have a far 
greater impact on meeting medication needs of populations than the relatively 
small number of psychologists seeking to prescribe could. 
Primary care providers are more widely distributed than mental health 
professionals, who tend to cluster in urban and suburban areas, and 
consequently are more likely to treat patients in rural areas (Xierali, Tong, 
Petterson, Puffer, Phillips, & Blazemore, 2013).  Thus, integrated care models 
that incorporate professionals who are skilled to coordinate a range of treatments, 
including psychological services, along with medical care by primary care 
providers, are promising avenues to improve mental health care access and 
outcomes (Butler et al., 2008). 
Under the Patient Protection and Affordable Care Act (PPACA) and the 
Wellstone-Domenici Mental Health Parity and Addiction Equity Act (MHPAEA), 
more Americans will have insurance with mental health benefits covered 
commensurately with general medical benefits.  The PPACA has many features 
intended to enhance and expand healthcare, including promotion of 
interprofessional care.  Consequently, interest in interprofessional collaborative 
care has been burgeoning.  Recently, several organizations have drafted 
guidelines to support curricula to help prepare future health and mental 
healthcare providers to engage in interprofessional collaboration (e.g., Institute of 
Medicine, 2013).  The World Health Organization (WHO; 2010) defines 
collaborative practice in healthcare as occurring “when multiple health workers 
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from different professional backgrounds provide comprehensive services by 
working with patients, their families, …and communities to deliver the highest 
quality of care across settings” (p. 13).  Moreover, “A collaborative practice-ready 
health worker is someone who has learned how to work in an interprofessional 
team and is competent to do so (p.7)”. 
The WHO considers interprofessional collaborations to be one of the most 
encouraging solutions regarding healthcare access and distribution problems and 
complex health-related challenges (HRSA, 2010; APA, 2013; WHO, 2010).  
Indeed, a shift is underway promoting interprofessional care in healthcare teams 
and the competencies clinicians need to provide team-based care 
(Interprofessional Education Collaborative Expert Panel, 2011).  Models for 
providing integrated care (Heath, Wise, & Reynolds, 2013, March) and for 
preparing psychologists to function in integrated teams are emerging (e.g., Cubic, 
Mance, Turgesen, & Lamanna, 2012). 
The Health Service Psychology Education collaborative supported by the 
APA (2013) Blueprint for Health Service Psychology Education and Training 
delineated diverse competencies for health service psychology. These include: 
the “interpersonal skills and communication …to relate effectively with 
professionals from other disciplines and demonstrate competence in 
interprofessional collaborative practice” (p. 29) as well as the consultation 
competence to “provide consultative psychological services to patients and their 
families, other health care professionals, and systems related to health and 
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behavior” (p. 31) …and that they ”are familiar with evidence-based consulting 
skills and methods…” (p. 31) 
Such developments arguably render the pursuit of RxP less compelling.  Non-
controversial measures are gaining ascendance, such as integrating 
psychologists in diverse healthcare settings, including primary care (American 
College of Neuropsychopharmacology, 2000; Bluestein & Cubic, 2009; Tovian, 
2006; Frank et al., 2003).  Deploying psychologists in primary care settings 
where they can provide interdisciplinary care in concert with prescribing health 
professionals (e.g., physicians, advanced practice nurses, physician assistants, 
consulting psychiatrists) who can manage medications in the context of patients’ 
other healthcare, is not only less costly (Blount et al., 2007; Chomienne et al., 
2011), but also obviates the risks of enabling prescriptive authority based on a 
training model considered controversial by various health professionals, including 
some psychologists, as will be discussed later in this article.   
Collaboration and Psychopharmacology Training 
Increasing psychologists’ education related to clinical psychopharmacology is 
generally accepted as having beneficial effects in enhancing how psychologists 
engage patients in regard to medications (Smyer et al., 1993).  However, 
enhancing psychologists’ understanding about psychoactive medications has 
never necessitated pressing for RxP (Smyer et al., 1993).  When the APA Ad 
Hoc Task Force on Psychopharmacology (Smyer et al., 1993) reviewed the 
desirability and feasibility of psychopharmacology prescription privileges for 
psychologists, it considered three potential levels of training for psychologists to 
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consider.  Level-2: Training for Collaborative Practice (a consultation-liaison 
model) was outlined by the APA Task Force (Smyer et al., 1993) but has been 
largely overlooked in favor of Level 3 training that provides a model for training 
psychologists to prescribe.  Training for collaborative practice would enhance 
psychologists’ knowledge of psychopharmacology to work cooperatively with 
other health professionals without taking the controversial step of seeking 
independent prescribing.  The collaborative level of training was more strongly 
favored by psychology graduate students (77%) as an option for their own 
training than prescribing (50%; Tatman et al., 1997).  The Task Force recognized 
that few psychologists would seek to prescribe (Smyer et al., 1993).  
Nevertheless, it seems curious that APA developed an agenda seemingly 
exclusively promoting RxP while consistently ignoring the collaboration model 
(i.e., we are not aware of guidelines developed for collaboration related to 
prescribing by other disciplines or efforts to promote the collaboration model).  
Disregarding the APA Task Force’s Collaborative Practice level seems 
particularly regrettable in that the APA (2007) Guidelines and Principles for 
Accreditation of Programs in Professional Psychology already mandate 
education and training that prepares psychologists to effectively consult with 
other health and mental healthcare providers so that graduates of all accredited 
programs presumably have basic skills in consultation, an important ingredient 
for successful collaboration.   
Moreover, collaboration is much closer to what most psychologists actually do.  
According to the APA Center for Workforce Studies (APA CWS, 2009) Survey of 
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Psychology Health Service Providers the vast majority of psychologists 
collaborate with psychiatrists (89%), primary care physicians (79%), other 
medical specialists (50%), nurse practitioners (51%), and over a quarter consult 
collaborate with physician assistants (27%).  Moreover, about 90% of 
psychologists regularly discuss medications with physicians and the majority 
provide information about medications to patients (APA CWS, 2009; Table 4a), 
an activity that enhances patient care, but does not hinge on psychologists 
prescribing.  These practice patterns of psychologists, in conjunction with the 
growing momentum of interprofessional team-based care, suggest that it is timely 
to take another, more serious look at Level-2 training outlined in the APA Task 
Force report (Smyer et al., 1993) as a potential means of achieving greater 
consensus in how the profession could most effectively establish collaborative 
roles for psychologists that capitalize on their on their clinical strengths.  Our view 
on this is not unique. The Canadian Psychological Association (CPA, 2010) Task 
Force on Prescriptive Authority for Psychologists recently recommended that 
active collaborative practice with prescribing professions was, “the optimal 
standard for contemporary psychological practices” (p. 27) rather than promoting 
RxP.   
Psychologists’ contributions to collaborative care leverages their expertise 
and recognized competencies in psychological assessment, intervention, and 
consultation, and also present opportunities to undertake research that can 
enhance healthcare.  Psychologists who wish to prescribe with training 
equivalent to other prescribers have always been free to explore more complete 
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biomedical training available in other health professions (e.g., physicians, 
advanced practice nurses, physician assistants).  If they wish to be recognized 
as providing pharmacologic interventions that would indisputably be considered 
on par with other types of prescribing professionals, it is recommended that their 
education and training be equivalent to it, beginning with obtaining the 
undergraduate scientific training and ending with more intensive and broader 
clinical medical supervised experiences.  For example, the Doctor of Nursing 
Practice degree, which is replacing the master’s level nurse practitioner degree, 
requires a minimum of 1000 supervised clinical hours.  
Consumers, employers, and healthcare organizations, such as the Institute of 
Medicine (2006), are increasingly concerned with promoting quality care and 
preventing avoidable medical errors.  In the current climate of increasing 
accountability within healthcare it is imperative that providers be sufficiently 
trained to provide services that meet industry standards and that professionals 
practice within the contours of their competence. 
Psychopharmacology Demonstration Project (PDP) 
Two decades ago the Department of Defense (DoD) undertook a pilot 
Psychopharmacology Demonstration Project (PDP) training 10 military 
psychologists to prescribe in a 2-year full time program.  When it was cancelled, 
the Government Accounting Office (GAO) report Need For More Prescribing 
Psychologists Is Not Adequately Justified concluded that, “training psychologists 
to prescribe medication is not adequately justified because the [Military Health 
Services System] MHSS has no demonstrated need for them, the cost is 
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substantial, and the benefits are uncertain.“ (p. 3).  NBC news later presented its 
Golden Fleece award to the project because of its poor cost effectiveness 
(California Psychiatric Association, n.d.).  
The final report of the Evaluation Panel of the PDP considered that,  
“… a 2-year program-one year didactic, one year clinical 
practicum that includes at least a 6-month inpatient rotation-can 
transform licensed clinical psychologists into prescribing 
psychologists who can function effectively and safely in the military 
setting to expand the delivery of mental health treatment to a 
variety of patients and clients.”  
It also deemed the psychologist PDP graduates to be weaker medically than 
psychiatrists (American College of Neuropsychopharmacology, 2000).  Rather 
than being assessed at the level of physicians, the PDP psychologists’ medical 
knowledge was assessed at a student level, which does not allow independent 
prescribing in any discipline in any jurisdiction.  PDP graduates, themselves, 
recommended against short cuts and reductions in required training.  Most said 
an intensive full-time year of clinical experience, involving inpatients, was 
indispensible in addition to the comprehensive didactics.  These features were 
not, however, included in the APA training model that was originally developed 
nor are they in the more recent iteration (APA, 2009).  Similarly, they are not 
systematically incorporated in contemporary clinical psychopharmacology 
training programs.  
APA Training Model and Current Training 
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In 1996 the American Psychological Association (APA) adopted the 
prescription privileges (RxP) agenda as a matter of policy, justifying it partly on 
the basis of the PDP.  It seeks to enable psychologists to prescribe 
independently, which is not currently the case in most jurisdictions for mid-level 
non-physician prescribers.  APA also endorsed a psychopharmacology training 
model that was shorter, less intensive, and less organized than the PDP.   
Eligibility for undertaking the training to prescribe merely requires psychologists 
graduate from an accredited doctoral psychology program, be licensed, and 
practice as a “health services provider” psychologist (APA, 2009).  Programs are 
required to have 400 contact hours covering eight domains and an unspecified 
length, breadth, or intensity of clinical supervised experience (APA, 2009).  The 
APA recommendations for education and training for prescribing is available 
online (APA, 2009). 
Several post-doctoral master’s-level psychopharmacology training programs 
have opened, although none are associated with medical schools.  Some are 
highly reliant on distance learning.  RxP programs are designed for psychologists 
to continue to practice during the training.  In contrast to the PDP, contemporary 
training for psychologists to prescribe is part-time and requires no inpatient 
training.  For example, the Alliant International University (2012) program 
advertises on its website, “Earn your degree at home on weekends.”  New 
Mexico State University (2011) acknowledges on its’ website that this truncated 
schedule may shape course coverage of material: “We will cover as many drug 
classes as we can in the time allotted.”	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Strikingly, the programs do not meet the APA’s (2007) own accreditation 
criteria that are in effect for psychology graduate, internship, and postdoctoral 
training.  That is, they are not required to be carefully scrutinized externally as 
are other levels of clinical training in psychology and as are other prescribing 
disciplines’ training programs.  Even APA’s (2009) revised psychopharmacology 
training model describes training that is narrower and less rigorous than the PDP 
training.  
Although RxP proponents have acknowledged that the PDP training was 
more consistent with core medical training models in terms of didactics focused 
on biochemistry, pathophysiology, and clinical medicine than current clinical 
psychopharmacology training programs (McGrath, 2010), they typically dismiss 
the relevance of this training and contend that supplementary hours in post-
doctoral training in psychopharmacology address these deficiencies in training. 
The absence of rigorous testing of psychologists’ foundational biomedical and 
scientific deficits precludes understanding their effects.  We question how 
sufficiently foundational deficiencies can be overcome and the advanced 
knowledge and clinical experience for prescribing can be gained in relatively 
abbreviated and distance learning training programs.  We remain skeptical of the 
proposition that psychologists might be able to master more quickly the complex 
nexus of knowledge and skills for prescribing and managing medications than 
learners in other disciplines.   
Some might argue that the relatively cursory training for RxP currently 
available is a form of “bait and switch” from the more robust PDP training that 
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was used to justify RxP originally.  The relatively more condensed nature of 
existing training seems likely to render it inferior to that provided in the PDP as 
well as relative to the training of other prescribers.  It also raises questions about 
the breadth, depth, and quality of such training.  For example, how can 
consumers and policy makers be assured what other prescribers learn in longer 
time frames, but that is excluded from an abbreviated curriculum, is not important 
in maximizing clinical outcomes?  After all, when medications enter the human 
body, they do not just affect emotional regulation within the brain, but have 
broader physical effects across organ systems (Stuart & Heiby, 2007) that may 
interact with other classes of medication. 
Differences Between Psychology and (Other) Prescribing Disciplines 
Graduate training in psychology differs substantively from other health 
professions from the start.  It requires neither undergraduate prerequisites nor 
graduate coursework in basic scientific and biomedical domains (e.g., biology, 
chemistry, organic chemistry, biochemistry, physiology, pathophysiology, etc.).  
Such courses are generally recognized as foundational to understanding 
biological and biochemical processes inherent in health and illness, how the 
human body responds to medications, and how interactions among systems and 
medications affect people (Heiby, 2010). 
RxP proponents concede that among non-physician health professionals, 
“…psychology has the core curriculum with probably the least overlap with 
traditional medical curricula” (Fox, DeLeon, Newman, Sammons, Dunivin, & 
Baker, 2009, p. 258).  The training paradigms are so different that only 7% of 
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psychology graduate students are estimated (Tatman, Peters, Greene & Bongar, 
1997) to have completed biology and chemistry undergraduate coursework 
considered adequate for prescribing by APA’s own ad hoc Task Force of experts 
when considering possible levels of psychopharmacology training (Smyer et al., 
1993). 
 In contrast to other health professions, to gain admittance to current RxP 
training programs, students are neither required to complete scientific 
foundational course work before enrolling nor to demonstrate competence in 
those domains through standardized admissions examinations (e.g., MCAT). The 
Psychopharmacology Examination for Psychologists (PEP), a 150-item, multiple 
choice test that is the only required testing for psychologists to prescribe 
contrasts with the more comprehensive, sequential testing such as the United 
States Medical Licensing Examinations (USMLE Step 1, 2 [CK and CS] and 3).  
Without more extensive objective testing following rigorous coursework, it is 
highly speculative to presume that the training psychologists receive could be 
equivalent to that of physicians or other prescribers, or be sufficient for managing 
medications, especially in people with complex comorbid conditions, such as 
older adults.  Without broader and in depth physical science education, 
biomedical knowledge, and experiential medical training, psychologist prescribing 
arguably constitutes an experiment for which there has been no objective, 
systematic, or comprehensive evaluation. 
Proponents of RxP summarily dismiss the importance of training that aligns 
with a medical school model requiring students to have a strong foundation in the 
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physical sciences (McGrath, 2010). This contention contrasts with the view of 
many (78.6%) psychologists, who believe that to prescribe psychologists should 
have equivalent training (Baird, 2010).  RxP proponents argue that because non-
physician prescribers (e.g., nurse practitioners) provide quality care that results in 
health outcomes similar to that provided by physicians (e.g., comparable control 
of asthma, diabetes and hypertension; health services utilization; patient 
satisfaction; Mundinger et al., 2000) even though they did not attend medical 
school, psychologists’ training need not be equivalent to physicians either.  
However, as noted by Heiby (2010), all other non-physician prescribers typically 
do have more extensive scientific (i.e., physical sciences) training at the 
undergraduate level than psychologists (see Figure 1).  Moreover, other 
prescribers and non-prescribing disciplines have broader and more intensive 
clinical medical training at the graduate level than is afforded by clinical 
psychopharmacology training for psychologists. 
The absence of scientific and medical training for psychologists in the 
undergraduate and graduate education sequence leads to questions about how 
abbreviated training after the education to become a psychologist could be 
adequate to enable prescribing at levels of knowledge and competence 
commensurate with other prescribers (see Table 1; Robiner et al., 2002; 2003). 
The absence of any undergraduate premedical scientific prerequisites to enter 
training to prescribe violates recommendations of APA’s own experts on the APA 
(1992) Ad Hoc Task Force on Psychopharmacology who stipulated that: 
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 “…retraining of practicing psychologists for prescription 
privileges would need to carefully consider selection criteria, 
focusing on those psychologists with the necessary science 
background…It would require students to have undergraduate 
science training similar to that required of other health service 
providers (e.g., nurses, pharmacists, allied health professionals, 
dentists, and/or physicians). It would also require a postdoctoral 
period of supervised clinical experience.” (p. 400).   
The potential for insufficient medical preparation is compounded by the reality 
that many psychologists train in settings outside of the health care system (e.g., 
schools, counseling centers, prisons, social service agencies).  For the APA to 
unilaterally determine that the basic scientific foundation required in other 
prescribing professions is unnecessary for psychologists suggests an 
underestimation of the complexity of the human body and drugs’ effects on it.  It 
also could signify inadequate respect of the contributions of those scientific 
disciplines to the understanding of the mechanisms and effects of medications 
whose elements are omitted.  This calculation to ignore scientific foundations 
assumedly derives from an objective to provide brief, affordable training so that 
more practicing psychologists might complete it.  Yet, even with this short cut 
relatively small numbers of psychologists currently prescribe.  Concerns about 
the abbreviated nature of the training fuels opposition to RxP, in various other 
health professions as well as among psychologists.  
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Whereas the interests and competencies of psychologists and psychiatrists 
overlap, there are differences in training and experience.  As Steven Kingsbury, 
M.D., Ph.D., a psychologist who later became a psychiatrist observed:  
“Studying the effects of medications on the kidney, the heart, 
and so forth is important for the use of many medications. 
Managing these effects is often crucial and has more to do with 
biochemistry and physiology than with psychology.  I was 
surprised to discover how little about medication use has to do 
with psychological principles and how much of it is just medical.” 
(Kingsbury, 1992, p. 5). 
He also contrasted the intensity and exposure to patients in his training in 
the two professions:  
“In my first month of residency training in psychiatry at a 
psychiatry emergency service I believe I saw more patients 
individually than in my entire graduate training [i.e., in 
psychology]” (Kingsbury, 1987, p. 155) 
Although anecdotal, these concerns and differences are not trivial. 
They are likely representative of the gaps between the medical 
preparation of psychologists and that of other prescribers.  
Psychologists’ Perspectives on Psychologist Prescribing 
The RxP movement developed within psychology as some psychologists 
sought to expand their scope of practice and, thereby, their clinical and economic 
opportunities.  It did not develop in response to entreaties from other health 
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professions, public health officials, or consumers, and was not supported by 
academic psychologists (Lavoie & Barone, 2006).  Although many psychologists 
support RxP in principle, unlike other professions with prescriptive authority, RxP 
remains controversial among psychologists, particularly when details of 
legislative proposals are considered (e.g., Hayes & Heiby, 1998; Heiby, 2002a, 
2010; Robiner et al., 2002, 2003; Wagner, 2002, Walters, 2001).   
Within psychology, opposing groups have included: the Society for a Science 
of Clinical Psychology (2001); American Association of Applied and Preventive 
Psychology (1998); Committee Against Medicalizing Psychology (CAMP; Pollitt, 
2003); and most recently, Psychologists Opposed to Prescription Privileges for 
Psychologists (POPPP; see www.poppp.org).   
In contrast to prescribing professions, most psychologists do not intend to 
prescribe (Baird, 2007; Campbell, Kearns, & Patchin, 2006), a trend that 
prevents RxP from becoming a viable strategy for counteracting the shortage of 
psychiatrists for which it is often touted as a remedy.  Even RxP advocates 
acknowledge that, “…only a minority of practitioners has evinced interest in 
seeking the ability to prescribe” (Fox et al., 2009, p. 257).   
Some psychologists seem to support RxP in theory, although practically 
speaking express no desire to pursue training or practice; others oppose it 
(Walters, 2001).  Interestingly, psychologists’ understanding of the details of 
prescribing training issues may be limited, so it is difficult to determine what 
individual psychologists think they support if they do endorse the RxP agenda.  
Baird’s (2007) survey revealed that most (78.6%) psychologists believed that to 
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prescribe psychologists should receive training commensurate with other non-
physician prescribers.   As noted above, APA’s current training model does not 
meet that objective in terms of foundational knowledge, intensity, or breadth of 
clinical experience, nor oversight through national accreditation. 
Professionals’ and Consumers’ Views of Psychologist Prescribing 
Although, there is consensus on the need for mental health services in the 
military, and more broadly throughout society, it is unclear whether training 
psychologists to prescribe is an effective means of addressing these needs.  
Instead, societal needs might be better served investing resources toward 
ensuring all mental health consumers have improved access to psychological 
services, especially evidence-based therapies, which are typically first-line 
treatments for a host of common mental health issues.  For example, after 
reviewing the published literature on antidepressants and other therapies, the 
National Health Service in England adopted cognitive behavioral therapy as a 
first-line treatment for mild and moderate depression and has invested £400 
million over the next four years to increase patient access to psychotherapy to 
treat depression and anxiety disorders, including plans to train up to 6,000 
therapists in cognitive behavioral therapy (Center for Mental Health, 2012). 
The RxP agenda is opposed by other health professionals and it undermines 
interprofessional relations (Bush, 2002).  The American Psychiatric Association 
and the American Medical Association have consistently lobbied against it 
although conceding they would have no quarrel with psychologists obtaining 
prescriptive authority as mid-level medical practitioners if their training was 
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equivalent to other mid-level practitioners (i.e., nurse practitioners, physician 
assistants).  Opposition to RxP notably extends far beyond organized medicine. 
The International Society of Psychiatric-Mental Health Nurses (2001) contends 
that nurses have an “ethical responsibility” to oppose RxP. 
Moreover, consumers are wary of RxP.  The National Alliance on Mental 
Illness (NAMI), the largest mental health advocacy and support organization, 
does not support RxP.  NAMI’s Executive Director noted that because, “these 
[psychoactive agents] are serious drugs with serious side effects…”we feel 
strongly that [prescribing] should be handled by someone with medical training” 
(Andrews, 2011). 
Although RxP advocates claim that psychologists prescribe without problems, 
there is little, if any, systematic, empirical evidence for the desirability, feasibility, 
safety, and cost effectiveness of RxP (Lavoie & Barone, 2006).  The unknown 
consequences of relative deficits in knowledge, experience, and competence 
associated with abbreviated training raise cautions (American College of 
Neuropsychopharmacology, 2000; Butler et al., 2008; Robiner et al., 2003).   As a 
public health issue, the fundamental concerns about RxP are patient safety and 
the quality of care that psychologists could deliver in prescribing relative to other 
prescribing professions.  Gaps in psychologists’ training to manage medications, 
relative to that of other prescribers, presumably persist, even after a psychologist 
might complete training conforming to the APA model.   
Potential Adverse Effects and Limitations of Psychoactive Medications 
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Psychoactive medications are commonly used in the treatment of anxiety, 
depression, insomnia, psychosis, and other conditions, and have become more 
accepted by consumers.  Nevertheless, they are powerful drugs with risks for 
significant adverse effects that require monitoring by qualified health 
professionals who can assess their effects.  This includes being prepared to 
discern whether symptoms are due to the prescribed medications, to other 
medications, to interactions between psychoactive medications and other 
medications, or whether they might indicate other medical conditions for which 
treatment is needed; not conditions for who which psychologists are trained to 
assess or treat. 
The potential for harm from psychoactive medications is considerable.  The U. 
S. Food and Drug Administration (FDA) requires black box warnings about risks 
of using antipsychotics with the elderly due to increased risk of death and other 
adverse effects (cardiac toxicity, stroke, infection, hyperglycemia) and for 
antidepressants in adolescents and young adults due to possible increased risk 
of suicidal ideation.  SSRIs can cause hematological disorders, including GI and 
retinal hemorrhage and other serious problems.  One study found the odds of 
mortality were 3.22 times higher for those using anxiolytic and hypnotic 
medications in the past month (Belleville, 2010).  A study of reports to the FDA 
from 1998 to 2005 revealed 3-fold increases in serious morbidity and mortality 
associated with adverse drug events (ADEs), with disproportionate incidence in 
the elderly (Moore, Cohen, & Furberg, 2007).  Two antidepressants, paroxetine 
and venlafaxine, were among the agents with the most frequent, serious 
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outcomes.  Antipsychotics (clozapine, risperidone, olanzapaine) and paroxetine 
were among drugs with most frequently suspected associated deaths. 
Complications associated with psychoactive medications include cardiac 
arrhythmias, insulin resistance, obesity, movement disorders, neuroleptic 
malignant syndrome, serotonin syndrome, sexual dysfunctions, and adverse drug 
event due to drug interactions (Stuart & Heiby, 2007).  Antidepressants and 
mood stabilizers account for an estimated 20,000 ADEs requiring treatment in 
emergency departments (EDs; Budnitz, Pollock, Weidenbach, Mendelsohn, 
Schroeder, & Annest, 2006).  Antipsychotics and benzodiazepines, respectively, 
accounted for 13,635 and 9,299 ADEs resulting in ED visits.  The medical risks 
and adverse effects associated with these agents, and the costs incurred with 
care to address them, warrant that prescribers have full understanding of human 
pathophysiology, morbidity, pharmacology, and the formulary beyond 
psychopharmacology (Stuart & Heiby, 2007).  Unfortunately, the truncated focus 
of psychopharmacology training programs for psychologists raises questions 
about whether the curriculum is sufficiently broad and intensive to address 
patients’ overall functioning. 
The rationale for RxP also is questioned as evidence mounts that 
antidepressants are used to treat mild to moderate conditions for which they may 
perform no better than placebo (Fournier et al., 2010), potentially resulting in 
overmedication.  It is unclear how knowledgeable and discerning potential 
prescribing psychologists are about both the adverse effects and the bounds of 
therapeutic effects.  Research suggests that some claims made to clinicians and 
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the public through medical journals and direct-to-consumer advertisement may 
be misleading, lack sufficient empirical support (i.e., well controlled and executed 
studies) and government oversight (Spielmans, Thiegles, Dent, & Greenberg, 
2008), making it essential that prescribers be sufficiently educated to understand 
for themselves the science underlying drugs’ action. 
Controversial Issues Associated With RxP 
Despite such concerns, the APA Practice Organization (APAPO) and its 
affiliates have mounted campaigns lobbying state legislatures to authorize RxP to 
psychologists who obtain postgraduate training based on the APA model.  
Proponents contend that allowing psychologists to prescribe would expand 
patient access to medications.  They posit that expanding psychologists’ scope of 
practice could enhance services for the underserved, such as in rural areas.  
Whereas access problems do exist and warrant remedy, claims about how well 
RxP would solve those problems deserve closer scrutiny and have been disputed 
(Lavoie & Barone, 2006; Politt, 2003; Robiner et al., 2002). 
For example, an article in the American Journal of Law & Medicine argues 
that RxP advocates disingenuously mislead legislatures to grant psychologists 
prescriptive authority (Pollitt, 2003).  The reality is that psychologists and 
psychiatrists have similar demographic distribution patterns, tending to practice in 
urban and suburban areas, rather than rural areas (see Figure 2).  Consequently, 
RxP is not likely to meaningfully attenuate rural prescriber workforce shortages. 
As noted earlier, developing interprofessional collaborations with PCPs is more 
likely to improve access to psychopharmological services.   
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Furthermore, mental health access issues in obtaining psychotherapeutic 
interventions and psychological assessments in both rural and urban areas may 
be more challenging than accessing pharmacotherapy (Campbell et al., 2006; 
Westra, Eastwood, Bouffard, & Gerritsen, 2006).  One study revealed that most 
family practitioners thought there were psychological and psychiatric services 
available in their communities for collaboration and consultation, and that they 
would be reluctant to refer patients to psychologists for pharmacological 
management (Bell, Digman, & McKenna, 1995).  Other approaches, such as 
telepsychiatry, offer the potential to compensate for some psychiatric workforce 
shortages (O’Reilly et al., 2007).  The shortage of psychiatrists neither logically 
nor prudently leads to the conclusion that psychologists should prescribe.  As 
members of the “de facto” mental health system, primary care physicians and 
mid-level providers can prescribe sufficiently well to meet many patients’ needs.  
Enhancing the systems and intensifying the training that underlie primary care 
providers’ mental health care delivery has the potential to further improve their 
prescribing quality as does enhancing psychologists’ capacity to function 
effectively in healthcare teams to coordinate care that is based on the interplay of 
the respective clinical strengths of their disciplines. 
The RxP Legislative Record 
APA has allocated considerable resources to promoting RxP.  By 2001, APA 
had spent more than $1 million on the RxP legislative agenda (DeLeon, 2002). 
The APAPO has provided grants to state psychological associations to support 
RxP lobbying.  The full amount that has been spent by the APA and groups of 
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RxP supporters is unknown.  The authors’ requests to the APAPO for financial 
records related to RxP went unanswered.  Conversely, the costs to counter 
legislative initiatives for RxP is not known.  Were RxP not a battleground, such 
lobbying efforts alternatively could be used collaboratively to promote a broader 
consensual agenda to advance mental health care and education within and 
across disciplines. 
The campaign to promote RxP has yielded modest success, which in 
behavioral terms might be characterized as intermittent reinforcement, 
suggesting that the RxP agenda is not likely to extinguish readily.  Guam was the 
first jurisdiction to pass RxP legislation in 1998.  Whereas RxP proponents hail 
this as an historic milestone in their movement, and widely cite it to justify 
promoting legislation in other areas, it seems misleading in that none of the 14 
psychologists licensed in Guam when this article was written are authorized to 
prescribe.  To our knowledge, this absence of an actual impact of Guam’s 
legislation on patient care in Guam or on psychologists’ activities there has never 
been acknowledged by RxP proponents as they have routinely cited it when 
advocating for RxP in discussions with their colleagues and legislators.   
New Mexico and Louisiana are the only states that have enacted RxP 
legislation in 2002 and 2004, respectively.  As of the writing of this article (i.e., 
about a decade after passage of enabling legislation), only 26 psychologists were 
authorized to prescribe in New Mexico (another nine are considered conditional) 
and only 71 in Louisiana. These numbers represent small percentages of the 
licensed psychologists by psychology boards in New Mexico (3.7%; 705) and 
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Louisiana (10.7%1 of 665), and a trivial fraction (0.1%) of the estimated 92,227 
clinically trained psychologists nationally (Substance Abuse and Mental Health 
Services Administration, 2012).  A review of the medical and nursing boards’ 
annual reports of those states reveals that these numbers are also much smaller 
than the number of advanced practice nurses (APN) and physician assistants 
(PA) who can prescribe in New Mexico (1,286 APN; 688 PA) and Louisiana 
(3,939 APN; 712 PA) respectively.  The influence of psychologist prescribers in 
addressing the medication needs in these states relative to other physician and 
non-physician prescribers would appear minimal based on the numbers alone, 
further raising questions about the actual impact of promoting RxP.   
Prescribing psychologists’ impact on the delivery of mental health services in 
those jurisdictions that authorize it has not been systematically assessed.  No 
large scale, objective evaluations of the impact of psychologists prescribing, or 
the potential problems associated with it, have been undertaken or published.  To 
the authors’ knowledge, none are planned.  The bounds of the “mission creep” 
seeking to broaden psychology’s purview to prescribing (Heesacker, 2005) are 
not known.  Some proponents propose that psychologists’ formulary should 
extend beyond psychopharmacology, on which the RxP movement was originally 
focused, and to which psychopharmacology training is principally dedicated, to 
other medications such as for weight loss, sleep disorders, chronic pain, and 
nicotine addiction (Earles, James, & Folen, 2006). 
Despite the expansive vision of RxP proponents, the superficial appeal of 
their rhetoric, and the disproportionate attention they have garnered within the 
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profession, the RxP legislative record has been lackluster.  Fox et al. (2009) 
estimated that at least 88 RxP legislative initiatives had been introduced in 21 
jurisdictions.  Using a somewhat different methodology that counts specific bills, 
we estimate that 170 initiatives to authorize psychologist prescribing have been 
introduced in about half of the U.S. states and two territories.  Figure 3 presents 
a map of RxP initiatives introduced between 1995 and 2012.  Of these bills, 167 
(98.2%) failed.  No states have enacted RxP legislation since 2004.  Some bills 
have failed to garner adequate support in legislatures.  Two met gubernatorial 
veto.  In 2013, additional bills in New Jersey and Illinois were defeated but are 
not included in this analysis because they technically may still be introduced in 
2013.  Although a precise, cumulative tally of the lobbying and other resources 
APA has marshaled to promote RxP is not available, the paltry record of 
enactment of RxP legislation reveals that the RxP agenda has been costly for the 
profession.  We believe the record deserves psychologists’ close attention.  It 
raises critical questions as to whether in lobbying for the still controversial RxP 
agenda professional organizations are exercising prudent stewardship of their 
resources (e.g., dues revenues).  
Other Effects of Promoting the RxP Agenda 
Pursuing RxP arguably has diverted the profession’s attention and resources 
from dealing with other matters, such as lobbying for additional funding levels for 
psychological services, graduate education, scientific research and preparing for 
medical homes and accountable care organizations (ACOs).  It has also 
distracted from focusing on the development of clinical practice guidelines and 
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policies that might better meet the needs of the public and practitioners, and from 
addressing other pressing professional matters (e.g., workforce, internship 
imbalance, equity, health reform and healthcare redesign, licensure mobility).   
Moreover, psychologists’ pursuit of RxP undermines interprofessional 
relations with disciplines that oppose RxP and is divisive among psychologists.  
Since just “a small minority of psychologists” has ever been expected to seek 
prescription privileges (Smyer et al., 1993), APA’s and APAPO’s allocations of 
resources to promote RxP have disproportionately served relatively few 
psychologists, rather than the broader profession.  These priorities and the 
attendant stewardship of resources diminishes support for the APA among 
psychologists who view the RxP as a misguided agenda and as incompatible 
with their values, and/or irrelevant to their aspirations, activities and needs.  
Over a decade ago, Heiby (2002b) proposed a moratorium on legislation 
enabling RxP due to the absence of sound outcome data related to the training 
model and the RxP movement’s divisiveness.  To the authors’ knowledge only 
one published study has sought to evaluate the impact, utility and safety of 
prescribing psychologists in practice.  Shearer and colleagues (2012) recently 
surveyed 47 primary care providers and residents who worked closely with a 
single (i.e., n = 1) prescribing psychologist in a family medicine clinic in an Army 
medical center.  Although they concluded their study provided evidence that 
prescribing psychologists “practice safely and effectively” (Shearer, Harmon, 
Seavey, & Tiu, 2012, p. 428), this conclusion based on essentially anecdotal data 
seems premature.   
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It is unclear to what degree Level-2 (i.e., Collaboration) trained psychologists, 
or other psychologists, would receive similar positive ratings by providing 
consultation, but not prescribing, and what additional services they could provide 
if not prescribing.  Additionally, as Shearer et al. note, the clear limitations in their 
methodology and sample limit their ability to answer questions about 
psychologist prescribing.  For example, they did not ask whether it would have 
been preferable to have a psychiatrist provide the psychopharmacological 
consultation (in person or via telehealth) or what concerns they would have about 
referring ill and complex patients.  They did not assess what medical phenomena 
related to prescribing psychologists might miss. Needed are more 
comprehensive investigations of prescribing psychologists (e.g., in New Mexioco 
and Louisiana) outside the structured setting of military facilities that yield reliable 
and valid data regarding patient outcomes (i.e., safety and effectiveness) and 
prescribing patterns in independent (i.e., not military) or less structured settings.  
Additionally, objective, independent data that evaluate error rates in psychologist 
prescribing and psychologists’ detection rates of adverse effects of medications 
and that move beyond anecdotal impressions are essential to addressing 
questions of whether and where prescribing psychologists provide quality care.  
Similarly, assessments of whether RxP meaningfully affects access to 
psychoactive medications in underserved areas is warranted.   
The history of RxP provides an important case study for psychologists’ role in 
promoting or supporting legislation.  It clarifies that unlike other APA policies and 
guidelines, the outcome of legislative initiatives is not determined by the 
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preferences of APA, its council, divisions, committees, taskforces, and members, 
but rather by a much broader group of stakeholders including governmental 
authorities, public policy groups, other health professionals and social scientists, 
consumers, as well as dissenting psychologists.  In promoting legislation APA 
should fully consider the risks, benefits and total capital needed to be expended 
to successfully pursue its legislative priorities such that it wisely manages its 
resources.  The authors recommend that APA’s legislative agenda and efforts 
focus on the goals and professional activities that benefit its overall membership, 
rather than supporting RxP, which benefit a small, if vocal, group of psychologists.   
Psychologists contribute substantively to the public health through the 
provision of diverse mental health and broader health services, research, and 
education, and deserve fuller recognition for the importance of their work.  The 
opportunities for psychologists to flourish in the dawning era of team-based 
health care are before us.  Psychologists’ success in this new era will be 
determined by the quality of their services, their outcomes, and their capacity to 
collaborate effectively.  We believe the public and the profession are best served 
by having psychologists provide those health services for which they are trained 
rigorously (e.g., assessment, psychotherapy, consultation, supervision, research, 
etc.).  In many cases, psychologists are indeed the most extensively trained 
among all health and mental health professionals for rendering them.  As 
interprofessional team-based care revolutionizes the delivery of healthcare, 
refocusing the profession’s psychopharmacology agenda to better prepare 
psychologists to collaborate with prescribers seems likely to be a more prudent, 
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impactful, and promising strategy that would be fully in synch with broader 
healthcare trends than continuing its undistinguished record in the pursuit of RxP.  
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Footnotes 
 
1 Because prescribing psychologists in Louisiana are now licensed by the 
Louisiana State Board of Medical Examiners (LSBME) but still have the option of 
being duly licensed by the Louisiana State Board of Examiners of 
Psychologists (LSBEP) as well, we could not determine what the total 
number of psychologists is in the state.  Hence, the figure cited, 665, is 
based on the LSBEP number data and may not include all of the psychologists.  
As such, the 10.7% estimate percentage of all Louisiana psychologists who can 
prescribe, is probably an overestimate of the actual proportion of prescribing 
psychologists.  Unfortunately, the LSBEP does not track the number of 
psychologists licensed with both boards. 	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Table 1  
 
Knowledge base and clinical proficiencies required for prescribing 
 
 
Psychopathology and 
Psychological Issues 
 
Medical Status Prior to 
Prescribing 
 
 
Response to Treatments 
 
Primary psychiatric 
conditions 
 
Comorbid medical 
conditions 
 
Knowledge of adverse 
reactions 
1. Side effects 
2. Toxic effects 
 
Comorbid psychiatric 
conditions 
 
Contraindications 
 
Ability to recognize, 
diagnose, and treat 
adverse reactions 
 
Prevalence and course of 
psychiatric conditions 
 
Medical effects of 
concurrent treatments 
1. Drug interactions 
2. Other treatments 
(e.g., dialysis, 
plasmapheresis) 
 
Ability to differentiate 
between physical and 
psychiatric effects of 
psychoactive agents and 
concurrent medications 
 
Knowledge of 
Nonpharmacologic 
treatment options 
 
Long-term effects of 
medications 
 
Other issues related to 
monitoring titrating, or 
discontinuing prescribed 
medications 
  
History of medication use 
 
 
Note. The education of psychologists typically addresses column 1, but neglects 
columns 2 and 3. Based on Robiner et al. (2002).  Request to reprint this table 
would be requested of Clinical Psychology: Science and Practice. 
 
Figure 1   
College Basic Science Prerequisite Courses for Admission to Health Science Programs 
 
Note. Multiply credits by 10 for estimated hours of instruction. These data were derived by 2013 survey of admission requirements to the largest 
programs in New Jersey (e.g., Farleigh Dickinson University, University of Medicine and Dentistry of New Jersey, Rutgers University). Although 
there were no physical or health sciences prerequisites for entry into the Ph.D. programs in Clinical Psychology, both the FDU and Rutgers 
curriculum included one course in biopsychology or behavioral neuroscience. The MS Clinical psychopharmacology program is an example of a 
program intended to train psychologists to prescribe, and requires considerably less than programs for other prescribers and non-prescribers.
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Figure 2. These data show the geographic distribution comparison for psychiatrists, primary care 
physicians (PCPs), and psychologists in Illinois. Data are provided for Illinois given that this state 
garnered the most attention and resources from the APA during the 2013 legislative session.  
Arguments for improving rural access were advanced by proponents but the data suggest similar 
practice locations with more PCP in outlying rural areas.  Other states present similar geographic 
distributions.   
Figure 3. Psychologist prescriptive authority legislative bills from 1995 through 2012 
 
 
 
